Primary study · included by 1 review
Health-related quality of life in long-term differentiated thyroid cancer survivors: A cross-sectional Tunisian-based study
Missaoui 2022 · Missaoui Abdel Mouhaymen, Hamza Fatma, Maaloul Mohamed, et al. · Frontiers in Endocrinology · 2022
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Xerostomia (pooled prevalence) Radioiodine (I131) therapy · between 2 and 6 months after RIT | Prevalence 0.37 [0.28, 0.47] | 4 studies · 392 participants | GRADE not reported |
1 including review in total.